Last reviewed · How we verify

NCT06219564: PAS

Total Placenta Previa Associated With the Placenta Accreta Spectrum.

Completed NA Last updated 23 January 2024
What this trial tests

NA trial testing Peripartum total abdominal hysterectomy (p-TAH) in Maternal; Procedure in 277 participants. Completed in 30 June 2023.

Timeline
1 November 2017
Primary endpoint
21 June 2023
30 June 2023

Quick facts

Lead sponsorSaglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposediagnostic
Enrollment277
Start date1 November 2017
Primary completion21 June 2023
Estimated completion30 June 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

Who can join

Adults 17 to 42, female only, with Maternal; Procedure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the reliability of placental magnetic resonance imaging measurements in predicting peripartum hysterectomy and neonatal outcomes in patients with total placenta previa.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Maternal; Procedure

Currently open trials in the same condition.

Other Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06219564.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing